AVITA Medical JP Morgan 2026.pdf

1、AVITA Medical:A Therapeutic Acute Wound Care CompanyAVITA Medical,Inc|Cary Vance,Interim CEOJ.P.Morgan Healthcare Conference(ASX:AVH,NASDAQ:RCEL)2Forward-Looking Statements&Legal DisclaimersThis presentation and the accompanying oral commentary may contain forward-looking statements within the meani

2、ng of the Private Securities Litigation Reform Act of 1995.These statements are predictions and subject to significant risks and uncertainties that could cause actual results to differ materially from those expressed or implied.Forward-looking statements may be identified by words such as“anticipate

3、,”“expect,”“intend,”“could,”“would,”“may,”“will,”“believe,”“continue,”“estimate,”“look forward,”“forecast,”“goal,”“target,”“project,”“outlook,”“guidance,”“future,”and similar words or expressions,as well as by discussions of future events or results.Forward-looking statements include,but are not lim

4、ited to,expectations regarding regulatory approvals;physician acceptance,endorsement,and use of our products;the realization of anticipated benefits from product approvals;the impact of regulatory actions;product liability risks;risks associated with international operations and expansion;and other

5、external factors including economic,industry,and political conditions beyond the Companys control.These statements are made as of the date of this presentation,and the Company undertakes no obligation to publicly update or revise any forward-looking statements,except as required by law.For additiona

6、l information and further discussion of these and other risks and uncertainties,please refer to the“Risk Factors”section of the Companys most recent Annual Report on Form 10-K and other filings with the Securities and Exchange Commission.AVITA Medicals products are Rx only.Please reference the Instr